J&J India to Pay Compensation of ~$28K per Patient for Faulty Hip Implant
Shots:
- Indian drug regulator CDSCO- has ordered J&J to pay Rs 20 Lakh (~$28K) as interim compensation to all patients received hip implants- after recommendation from government-appointed committee. Also J&J has to extend its medical management till 2025- along with compensation
- As per J&J 4-700 patients in India have received these implants however 3-600 patients yet to be track down. J&J has also agreed to pay $2.5B to 8-000 patients in 2013 for faulty implants in the US
- J&J has globally recalled ASR hip implants since 2010- based on leaking of chromium and cobalt which creates toxicity in human body
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com
